Top

Archives of Gynecology and Obstetrics

Published in:

01-06-2009 | Original Article

Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users

Authors: Husnu Gorgen, Murat Api, Aysu Akça, Ahmet Cetin

Published in: Archives of Gynecology and Obstetrics | Issue 6/2009

Abstract

Objective

The aim of the present study was to measure the treatment of menorrhagia and health-related quality of life (QoL) in Levonorgestrel-releasing intrauterine system (LNG-IUS) in Turkish women.

Materials and methods

We recruited 66 premenopausal women, aged 26–55 years, who had sought care in the previous year for menorrhagia. All patients were asked to complete a visual analog scale (VAS) form regarding pelvic pain, sexual life (libido) and general feeling of health. Patients filled the VAS form before LNG-IUS insertion and after 6 months.

Results

After the 6-month visit, PBAC score was condirebly decreased (p < 0.001). Six (10%) of the 60 patients PBAC score was higher than 75. VAS score for pelvic pain decreased from baseline to 6-month follow-up (4.32–3.55), and the libido and general feeling of health increased (4.27–4.95 and 3.47–6.87, respectively).

Conclusion

The LNG-IUS device in the trearment of menorrhagia has cost effective, less side effects and increse in the QoL.

Hurskainen R, Paavonen J (2004) Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 16:487–490. doi:10.1097/00001703-200412000-00009 PubMedCrossRef

Chrisman C, Ribeiro P, Dalton VK (2007) The Levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses. Clin Obstet Gynecol 50(4):886–897PubMedCrossRef

Lethaby AE, Cooke I, Rees M (2005) Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev CD002126

Higham JM, O’Brien PMS, Shaw RW (1990) Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97:734–739PubMed

Guyatt GH, Cook DJ (1994) Health status, quality of life, and the individual. JAMA 272(8):630–631. doi:10.1001/jama.272.8.630 PubMedCrossRef

Jenkinson C, Peto V, Coulter A (1994) Measuring change over time: a comparison of results from a global single item of health status and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia. Qual Life Res 3:317–321. doi:10.1007/BF00451723 PubMedCrossRef

Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA (2002) Hysterectomy surveillance—United States, 1994–1999. MMWR CDC Surveill Summ 51:1–8

Clarke A, Black N, Rowe P, Mott S, Howie K (1995) Indications for and outcomes of total abdominal hysterectomy for benign disease; a prospective cohort study. Br J Obstet Gynaecol 102:611–620PubMed

Dwyer N, Hutton J, Stirrat GM (1993) Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorraghia. Br J Obstet Gynaecol 100:237–243PubMed

10.

Sculpher MJ, Dwyer N, Byford S, Stirrat GM (1996) Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol 103:142–149PubMed

11.

Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A et al (2001) Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 357:273–277. doi:10.1016/S0140-6736(00)03615-1 PubMedCrossRef

12.

Coulter A, Peto V, Jenkinson C (1994) Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 11:394–401. doi:10.1093/fampra/11.4.394 PubMedCrossRef

13.

Shankar M, Kadir RA (2008) Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 14:15–20PubMed

14.

Myers ER, Steege JF (1999) Risk adjustment for complications of hysterectomy: limitations of routinely collected administrative data. Am J Obstet Gynecol 181:567–575. doi:10.1016/S0002-9378(99)70494-1 PubMedCrossRef

15.

Inki P (2007) Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 75:161–166. doi:10.1016/j.contraception.2006.12.016 CrossRef

16.

National Collaborating Centre for Women’s and Children’s Health (NICE) Heavy menstrual bleeding. Published by the RCOG Press at the Royal Collage of Obstetricians and Gynaecologists, London. www.rcog.org.uk

17.

Hurskainen R (2006) Managing drug-resistant essential menorrhagia without hysterectomy. Best Pract Res Clin Obstet Gynaecol 20(5):681–694. doi:10.1016/j.bpobgyn.2006.03.003 PubMedCrossRef

18.

Bourdrez P, Bongers MY, Mol BWJ (2004) Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrelreleasing intrauterine device, or hysterectomy. Fertil Steril 82:160–166. doi:10.1016/j.fertnstert.2003.12.025 PubMedCrossRef

19.

Vuorma S, Teperi J, Hurskainen R, Aalto AM, Rissanen P, Kujansuu E (2003) Correlates of women’s preferences for treatment of heavy menstrual bleeding. Patient Educ Couns 49(2):125–132. doi:10.1016/S0738-3991(02)00069-1 PubMedCrossRef

20.

Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118(8):622–629PubMed

Title: Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users
Authors: Husnu Gorgen
Murat Api
Aysu Akça
Ahmet Cetin
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 6/2009
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-008-0834-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users

Abstract

Objective

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2009

Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine

Night/day ratio as predictor of preeclampsia in normoalbuminuric, diabetic women: early signs of blood pressure disorders

Microwave endometrial ablation and pregnancies: case series

The effect of symptom duration in epithelial ovarian cancer on prognostic factors

Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1

Scar endometriosis after a laparotomy for uterine perforation as a complication of dilatation and curettage